Browsing Tag
STAR Trial
1 post
Myopia drug breakthrough: Sydnexis’ SYD-101 approved in Europe, Ryjunea launch next
Sydnexis, Inc., a privately held U.S. biopharmaceutical company, secured a critical regulatory victory on June 5, 2025, with…